Neurology Alert – September 1, 2004
September 1, 2004
View Issues
-
Resolution of the Prion Debate?
The means by which prions cause neuropathologic damage remains to be established. -
A New Treatment for Vestibular Neuritis
Methylprednisolone significantly improves the recovery of peripheral vestibular function in patients with vestibular neuritis, whereas valacyclovir does not. -
Steroids for Neuromuscular Disease: What’s Proven, What’s Not?
Absence of evidence-based medicine is both humbling, as well as a reminder of how substantial a role the art and oral tradition of medicine plays in the care of neurologic patients. -
Pregnancy and Multiple Sclerosis: Predictors of Postpartum-Relapse
These studies provide additional data about the higher risk of relapse, and the greater potential for progression of disability following childbirth. -
Antiplatelet Therapy for Secondary Stroke Prevention: MATCH Trial Resul
The MATCH data provide quite strong evidence that the clopidogrel-aspirin combination is a less favorable option than previously thought, but its use may not be completely contraindicated. -
Melatonin is Effective for Sleep Disorders in Young People with Developmental Delays, but has Variable Effects on Seizures
It seems prudent to strongly consider use of melatonin in our cognitively delayed patients with disordered sleep, but to monitor those with epilepsy very closely for exacerbation, and withdraw the drug. -
Highlights of the 9th ICADRD Meeting
The hundreds of presentations at this meeting provided encouraging evidence that existing Alzheimers therapies may have greater benefits than first realized, and that a new generation of potential disease-modifying therapies for AD may be on the way. -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch: New Clinical Guidelines on Cholesterol Management
The National Cholesterol Education Program, a product of a collaboration of the National Heart, Lung, and Blood Institutes, the American College of Cardiology, and the American Heart Association, has updated its clinical practice guideline on cholesterol management.